Medical Weight Loss

A medical weight-management program is a provider-guided approach to weight loss and long-term health. It begins with a medical evaluation rather than a one-size-fits-all diet or product.

Your provider may review your weight history, eating patterns, activity level, medications, health conditions, prior weight-loss attempts, and relevant laboratory information.

Depending on your needs and eligibility, your plan may include nutrition guidance, lifestyle support, follow-up visits, and prescription treatment options when appropriate.

Your provider first evaluates whether there are medical, metabolic, hormonal, medication-related, or lifestyle factors contributing to weight gain or difficulty losing weight.

If treatment is appropriate, your plan may include realistic goal setting, nutrition and activity guidance, medication review, prescription options, and ongoing monitoring.

Follow-up matters. Your provider may adjust, pause, or discontinue treatment based on your response, side effects, health changes, and clinical judgment.

Vitalé offers medical weight-management consultations for patients in Manasquan and surrounding areas. The goal is to create a plan that is appropriate for your health, goals, and risk profile.

HCG is not presented as an FDA-approved or evidence-based treatment for weight loss. FDA states that HCG has not been shown to be effective for treating obesity and is not approved for weight loss.

If you are interested in medical weight management, your provider can discuss appropriate options during consultation.

Semaglutide and tirzepatide are prescription medications that may be discussed as part of a medical weight-management plan for eligible patients.

Some branded GLP-1 or GIP/GLP-1 medications are FDA-approved for chronic weight management in specific adults with obesity or overweight with weight-related conditions. Compounded versions are not FDA-approved and require clear discussion of risks, limitations, quality considerations, and alternatives.

Your provider will determine whether medication is appropriate based on your medical history, current medications, treatment goals, contraindications, and follow-up needs. Medication is not appropriate for every patient.

Semaglutide is a GLP-1 receptor agonist used in several prescription medications. Certain semaglutide products are FDA-approved for chronic weight management in eligible patients. Treatment suitability depends on the specific medication, your health history, current medications and clinical evaluation.

Tirzepatide acts on both GIP and GLP-1 receptors. Certain tirzepatide medications are FDA-approved for chronic weight management in eligible adults. Your provider can discuss whether a tirzepatide-based treatment is appropriate and currently